Elevance Health Inc. (ELV)
NYSE: ELV · IEX Real-Time Price · USD
533.73
+0.81 (0.15%)
Apr 24, 2024, 4:00 PM EDT - Market closed

Elevance Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1998
Net Income
5,9875,8946,1584,5724,8073,7503,8432,4702,5602,570
Upgrade
Depreciation & Amortization
1,7451,6751,3021,1541,1331,132891912907.9851
Upgrade
Share-Based Compensation
28926425528329422617011152.4122.5
Upgrade
Other Operating Activities
405666494,679-173-1,281-719-223691.6-173.9
Upgrade
Operating Cash Flow
8,0618,3998,36410,6886,0613,8274,1853,2704,2123,369
Upgrade
Operating Cash Flow Growth
-4.02%0.42%-21.74%76.34%58.37%-8.55%27.98%-22.36%25.01%10.39%
Upgrade
Capital Expenditures
-1,296-1,152-1,087-1,021-1,077-1,208-791-584-602.9-626.6
Upgrade
Acquisitions
-1,552-649-3,476-1,9760-1,760-2,0800-638.9740
Upgrade
Change in Investments
-2,700-2,338-4,056-3,433-1,9191,929-1,749319426.4-269.5
Upgrade
Other Investing Activities
-24-421-1,019-894204-220-462-249-336.1-818.8
Upgrade
Investing Cash Flow
-5,572-4,560-9,638-7,324-2,792-1,259-5,082-514-1,151.5-974.9
Upgrade
Dividends Paid
-1,395-1,229-1,104-954-818-776-705-684-656.6-480.7
Upgrade
Share Issuance / Repurchase
-2,524-2,134-1,697-2,524-1,514-262-1,773120-1,329.8-2,697.5
Upgrade
Debt Issued / Paid
7391,7952,343188608-1,0863,724360-892.3763.7
Upgrade
Other Financing Activities
-169250881723-542-117-819-595-214.6592
Upgrade
Financing Cash Flow
-3,349-1,318423-2,567-2,266-2,241427-799-3,093.3-1,822.5
Upgrade
Exchange Rate Effect
-1-14-1070-245-5.3-7.1
Upgrade
Net Cash Flow
-8612,507-8618041,003325-4661,962-38.2564.8
Upgrade
Free Cash Flow
6,7657,2477,2779,6674,9842,6193,3942,6863,6092,743
Upgrade
Free Cash Flow Growth
-6.65%-0.41%-24.72%93.96%90.30%-22.83%26.36%-25.57%31.59%12.18%
Upgrade
Free Cash Flow Margin
3.95%4.63%5.25%7.93%4.78%2.84%3.77%3.17%4.56%3.71%
Upgrade
Free Cash Flow Per Share
28.7930.3429.9838.8719.6610.1313.2210.2013.8210.16
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).